We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPO icon
576
XPO
XPO
$25.1B
$89.6M 0.01%
734,364
-22,596
-3% -$2.42M
DELL icon
577
Dell
DELL
$321B
$89.2M 0.01%
781,500
+470,642
+151% +$43.9M
MORF
578
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$88.8M 0.01%
2,523,586
+300,958
+14% +$10.1M
EVRG icon
579
Evergy
EVRG
$19.3B
$87.3M 0.01%
1,635,174
-2,563,670
-61% -$131M
PAC icon
580
Grupo Aeroportuario del Pacifico
PAC
$12.6B
$87M 0.01%
533,156
-33,948
-6% -$5.26M
KMPR icon
581
Kemper
KMPR
$1.57B
$86.9M 0.01%
1,403,504
-2,899,436
-67% -$166M
LNTH icon
582
Lantheus
LNTH
$6.58B
$86.5M 0.01%
1,389,226
-244,643
-15% -$14.4M
FN icon
583
Fabrinet
FN
$20.7B
$86.2M 0.01%
455,786
-104,007
-19% -$20.9M
ATKR icon
584
Atkore
ATKR
$3.17B
$85.5M 0.01%
449,323
+4,852
+1% +$776K
CLH icon
585
Clean Harbors
CLH
$16.8B
$84.9M 0.01%
421,591
-43,215
-9% -$7.77M
NET icon
586
Cloudflare
NET
$117B
$84.7M 0.01%
875,183
+149,866
+21% +$13.6M
XNCR icon
587
Xencor
XNCR
$1.71B
$84.5M 0.01%
3,819,656
+335,881
+10% +$7.26M
DLTR icon
588
Dollar Tree
DLTR
$25B
$84.3M 0.01%
633,223
+214,912
+51% +$29.6M
AXON
589
Axon Enterprise
AXON
$49.1B
$83.4M 0.01%
266,549
-969
-0.4% -$269K
ITCI
590
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$83.3M 0.01%
1,203,968
-56,929
-5% -$3.91M
RMD icon
591
ResMed
RMD
$32.7B
$82.5M 0.01%
416,761
+11,908
+3% +$2.18M
HR icon
592
Healthcare Realty
HR
$6.6B
$81.8M 0.01%
5,782,253
+158,342
+3% +$2.39M
WEC icon
593
WEC Energy
WEC
$35.9B
$81.1M 0.01%
987,791
-700,103
-41% -$56.3M
CWST icon
594
Casella Waste Systems
CWST
$5.78B
$80.8M 0.01%
817,541
-80,023
-9% -$7.17M
KROS icon
595
Keros Therapeutics
KROS
$216M
$80.7M 0.01%
1,218,504
+176,803
+17% +$10.5M
DUOL icon
596
Duolingo
DUOL
$6.44B
$80.5M 0.01%
364,755
+154,659
+74% +$31.5M
AFRM icon
597
Affirm
AFRM
$26B
$80.3M 0.01%
2,154,999
-2,586,189
-55% -$103M
CACI icon
598
CACI
CACI
$14.8B
$80.1M 0.01%
211,488
-1,291
-0.6% -$459K
RCKT icon
599
Rocket Pharmaceuticals
RCKT
$368M
$79.3M 0.01%
2,943,160
+314,086
+12% +$8.92M
EXEL icon
600
Exelixis
EXEL
$12.6B
$79.2M 0.01%
3,338,238
-311,435
-9% -$6.92M

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.